Compare Stocks → The Gold Grab of the Century (From Colonial Metals) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:EMHNYSE:SYA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shsSYA(SYA)$32.02$0.00$20.24▼$32.02N/AN/A1.08 million shsN/A10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%SYA(SYA)0.00%0.00%0.00%0.00%0.00%Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new reportMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASYA(SYA)N/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMHEmerald Health TherapeuticsN/AN/AN/AN/ASYA(SYA)N/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64SYA(SYA)N/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/ASYA(SYA)N/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/ASYA(SYA)$0.441.37%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMHEmerald Health Therapeutics35.452.972.61SYA(SYA)N/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMHEmerald Health TherapeuticsN/ASYA(SYA)N/AInsider OwnershipCompanyInsider OwnershipEMHEmerald Health TherapeuticsN/ASYA(SYA)N/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableSYA(SYA)N/AN/AN/ANot OptionableEMH, AQI, GCM, HXG, and SYA HeadlinesSourceHeadlineIncrease in CCSC entrance fee eyedphilstar.com - May 3 at 8:20 PMJoey de Leon earns ire after ‘weight-gain’ remark about Miles Ocampomsn.com - May 3 at 10:31 AMCelebrating Ka-pandas: The New Wave of Road Heroesmanilastandard.net - May 2 at 3:36 PMPolice claim twin murder in condo isolated casesunstar.com.ph - May 2 at 3:36 PMFrancine Diaz, Orange and Lemons go viral following conflict in performance schedulemsn.com - May 1 at 11:56 PMBarbers hits background of ex-PDEA agent invited by Senatemsn.com - May 1 at 1:55 PMPNP-Davao vows to continue search for Quiboloysunstar.com.ph - May 1 at 1:55 PMDid Francine Diaz cause Orange & Lemons to walk out on stage?msn.com - May 1 at 8:55 AMAnne Curtis meets ENHYPEN's Jake and Sunghoon in an elevatormsn.com - April 30 at 10:54 PMJob-hopping Filipino GenZs on 4th or 5th gigs share whygmanetwork.com - April 30 at 10:54 PM7 hurt when lightning struck during wedding receptiongmanetwork.com - April 30 at 10:54 PMMCWD willing to talk with “OIC” gen mngrphilstar.com - April 30 at 12:53 PMBell-Kenz pharma exec tells senators: We are a law-abiding entitymsn.com - April 30 at 7:52 AM2 cops relieved for alleged misconduct in 'peryahan'gmanetwork.com - April 30 at 2:49 AMMCWD, cpa file complaints before op, Ombudsman: Cases rain on Ramaphilstar.com - April 29 at 4:47 PMRaves for ‘RAVS’philstar.com - April 29 at 4:47 PMRonnie O’Sullivan vs Jackson Page LIVE: Latest scores and updates from World Snooker Championshipmsn.com - April 27 at 3:30 AMResidents outside PRO-10 camp protest access road closuregmanetwork.com - April 26 at 12:24 PMTown gearing up for May Day fun dayshropshirestar.com - April 26 at 12:24 PMFilipino’s tweet on excessive gravy consumption goes viral, sparks discussion onlinemsn.com - April 26 at 12:24 PMRunners needed to compete for SYA charity at half marathon and 10kcharitytoday.co.uk - April 26 at 7:24 AMHigh school regional track and field results from Class 5A and Class 3A meetstheadvocate.com - April 25 at 4:22 PMXander Arizala says he and Gena Mago have broken up: “Napabayaan ko sila”msn.com - April 25 at 11:21 AMAubrey Miles has witty clapback at netizen who cringed at her branded outfitmsn.com - April 25 at 11:21 AMCompany DescriptionsEmerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.(SYA)NYSE:SYASymetra Financial Corporation is a financial services company in the life insurance industry. The Company's products are distributed domestically in all states and the District of Columbia through benefits consultants, financial institutions, broker-dealers and independent agents and advisers. It has three divisions: Benefits Division, Retirement Division and Individual Life Division. The Company's Benefits Division provides medical stop-loss insurance, group life and disability income (DI) insurance, and limited benefit medical insurance as its principal products. The Company's Retirement Division provides products that help its customers prepare for retirement and includes the Deferred Annuities and Income Annuities segments. The Company's Individual Life division sells life insurance products. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
